Regeneron Investigational Site

Palo Alto, California

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Dermatitis, Atopic Clinical Trial
Safety, Pharmacokinetics and Efficacy of Dupilumab in Patients ≥6 Months to
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Palo Alto, CA
Click here to add this to my saved trials